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Autism is one of three developmental disorders in the group known
as the autism spectrum disorders (ASDs). This spectrum of disor-
ders has an estimated prevalence of one in 150 children. Increased
awareness and diagnosis has led to an explosion of information
available about the disorder. This explosion has made scientific
research more readily available, along with inaccurate and spur-
ious information. Autism is a disorder without a known cause or
cure and few treatments with sufficient evidence to indicate
effectiveness. Due to the variable presentation of autism, there is
no single intervention that is effective for all individuals. The com-
plexity of the disorder is addressed by research and practice across
several disciplines, including education, psychology, psychiatry,
neurology, genetics, and internal medicine. This resource guide
will introduce the range of autism spectrum disorders, its various
perspectives and treatments, and will point librarians and patrons
to introductory resources to provide links for further learning.
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INTRODUCTION
We hear about autism frequently these days, particularly warnings that its
prevalence is increasing. Autism Speaks states that one in 150 children have
autism.1 Other claims are more nebulous and come from friends, family,
co-workers, and the Internet. Often these statements are powerful, easy to
remember, and seemingly straightforward. ‘‘Autism is an epidemic.’’ ‘‘Autism
is caused by the toxins in MMR vaccines.’’ ‘‘People with autism don’t have
feelings.’’ ‘‘Kids grow out of it.’’ ‘‘Autism can be cured’’ . . .with medication,
a carefully controlled diet, hyperbaric chambers, music therapy, hippotherapy,
and so on.
Distinguishing popular opinion from statements supported by scientific
evidence is particularly challenging in the case of autism. The most signifi-
cant challenge for professionals and patients alike is not the lack of under-
standing about the cause of autism. Rather, it is the abundance of
conflicting information, even research data, from the various fields studying
autism and the organizations that stand to benefit from perpetuating inac-
curacies. There are many misconceptions about autism, which is why finding
quality, scientifically based information is particularly difficult for this topic.
One of the most challenging misconceptions is that ‘‘autism’’ is a single dis-
order; another is to consider those diagnosed with ASD as a homogeneous
group when discussing treatments.
Autism is just one of a group of disorders known as Autism Spectrum
Disorders (ASDs). This group contains three disorders distinct from other
developmental disabilities due to the impairment in social relating skills.
The autism spectrum includes three distinct disorders: autistic disorder
(what is typically called autism), Asperger’s Disorder, and Pervasive Devel-
opmental Disorder – Not Otherwise Specified (PDD-NOS). ASDs are desig-
nated as a spectrum of disorders because of the wide range of signs and
symptoms that can be displayed, ranging from relatively mild to severe.
This designation is partly due to the lack of a known cause; in fact, it is
likely that autism spectrum disorders are caused by a complex confluence
of environmental exposure and genetic susceptibility. Although there is no
causative evidence, the prevalence of autism in people with other medical
conditions such as Fragile X Syndrome is higher than expected.2 However,
there is insufficient scientific evidence to suggest that the MMR vaccine
causes autism, either due to the vaccine itself, the presence of thimerosal
(no longer in the MMR vaccine), or the simultaneous administration of
multiple vaccines.3
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Autism is a developmental disorder characterized by significant impair-
ments in social interaction, communication, and restricted or repetitive
behaviors or interests4 to the extent that they interfere with the functioning
of the individual. A medical diagnosis is (always, according to the DSM-IV
criteria) made based on the individual’s development and functioning
between birth and three years of age. This narrow window for direct obser-
vation by a clinician can present significant challenges in the diagnostic pro-
cess. If a child is not evaluated prior to age three, the diagnosis is made using
medical records, school records, and parent report, among other documents.
Many pediatricians and family physicians are not comfortable making a diag-
nosis due to lack of training; subsequently, ASD diagnosis is often made by a
psychiatrist or clinical psychologist. In the school system, the classification is
made by a team, usually consisting of the teacher of record, school psychol-
ogist, autism consultant, speech therapist, and occupational therapist. In both
the medical and educational systems, diagnosis (medical) or classification
(school system) is required for an individual to receive services. These
lengthy and difficult processes are exacerbated by the lack of appropriately
trained providers available.
Even after diagnosis, individuals with an ASD and their families face
many challenges in obtaining appropriate treatment. The complex and vari-
able nature of the spectrum combined with significant impairments in social
relating skills means that successful interventions are multifaceted, long-term,
and expensive. The research bases of education and psychology provide
some clues to the types of programs that have significant empirical support.
However, it is important to keep in mind that no single program is effective
for all individuals with an ASD.5 The components of successful programs
include structured treatment using principles of Applied Behavior Analysis
(ABA); parent involvement in all areas; early intervention; intensive treat-
ment; programming for generalization; specific curricula that emphasize
social and communication skills; and integration with peers when possible.5
Currently, there is only one FDA-approved medication, RisperdalTM, for
symptoms of irritability associated with autism.6
SITE SELECTION CRITERIA
Each site listed here was selected because it met the following criteria.
. A significant portion of the information provided is based on scientific
research
. Does not advocate or propose a ‘‘cure’’
. Does not advocate expensive treatments or treatments that may cause harm
. Does not advocate one treatment for all individuals on the spectrum
. Recognition of the individuality of presentation of the disorder across
people and growth throughout the lifespan.
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The preponderance of government sites is due to relative uncertainty
regarding the cause of and most appropriate treatments for ASDs. Research
examining the physiological mechanisms of autism have begun relatively
recently and still have far to go. The controversy over possible causes and
treatments is reflected in the endorsements of many parent groups and non-
profit organizations. The intense desire for a cure often leads parent groups
and nonprofit organizations to endorse treatments without sufficient
evidence of effectiveness. The sites selected for this guide may be overly
conservative when considering treatment options, but the information and
conclusions are based firmly on scientific evidence.
WEB RESOURCES
The sites are broadly organized according to common questions faced by
individuals with an ASD and those who care for them. Due to the enormous
variety of intervention approaches from multiple disciplines, this guide can-
not be considered comprehensive. Instead, the topics and resources included
should be considered starting points for those learning about autism
spectrum disorders.
General Information, Diagnosis, and Screening
CDC Autism Information Center
<http://www.cdc.gov/ncbddd/autism/>
The CDC Autism Information Center serves as a portal for information from
National Centers and several NIH departments. A wide array of topics
includes an introductory overview, screening and diagnosis, treatment and
therapy, FAQ, relevant CDC activities, recent publications and news alerts,
and tools. This site is an excellent place to begin learning about ASDs due
to the quality, current information for parents, educators, clinicians, and
researchers. A particularly useful feature on this portal are the links to rele-
vant Congressional and CDC activities, which provide current and historical
information. The CDC activities link will direct users to the ‘‘Learn the Signs.
Act Early.’’ campaign page, from which users can request information
packets on developmental milestones at no cost.
CDC: Immunization Safety and Autism: Thimerosal and
Autism Research Agenda
<http://www.cdc.gov/ncbddd/autism/documents/
vaccine_studies.pdf>
As of January 2009, this document summarizes the vaccine studies completed
or being conducted by the CDC. A brief description of each study, estimated
publication date, and focus area are provided.
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MedlinePlus HealthTopics: Autism
<http://www.nlm.nih.gov/medlineplus/autism.html>
The MedlinePlus site provides information in consumer-friendly language:
‘‘Children with autism might have problems talking with you, or they might
not look you in the eye when you talk to them. They may have to line up their
pencils before they can pay attention, or they may say the same sentence
again and again to calm themselves down. They may flap their arms to tell
you they are happy, or they might hurt themselves to tell you they are not.
Some people with autism never learn how to talk.’’
The scope is primarily medical and health information related to ASDs,
with significant coverage of current research including full text of open
access journal articles. A special feature is the option of viewing the content
in several languages, including Spanish, Russian, and Somali.
NICHD Autism Overview: What We Know
<http://www.nichd.nih.gov/publications/pubs/upload/
autism_overview_2005.pdf>
Designed primarily for parents, this booklet, published by the National Insti-
tute of Child Health and Human Development in 2005, includes a list of refer-
ences for health care professionals. The organization of content into common
questions is consumer-friendly, and the glossary is well-written, for example:
‘‘This fact sheet offers broad information about autism and answers some of
the more common questions that parents and families often have about the
disorder. You can get more detailed information on these topics from the
sources listed in the References section. Keep in mind that the articles listed
are geared toward scientists and researchers, so the information is more
technical than what is presented here.’’
National Institute of Mental Health (NIMH): Autism
Spectrum Disorders
<http://www.nimh.nih.gov/health/publications/autism/
nimhautismspectrum.pdf>
This NIMH booklet provides a broad overview of ASDs, including the his-
tory of the disorder, description of the spectrum disorders, the diagnostic
process, treatment options, and other relevant topics for parents. Several
sections provide direct recommendations to parents. The language may
be somewhat challenging for individuals with low literacy. For example:
‘‘There is no single best treatment package for all children with ASD. One
point that most professionals agree on is that early intervention is important;
another is that most individuals with ASD respond well to highly structured,
specialized programs. Before you make decisions on your child’s treatment,
you will want to gather information about the various options available.
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Learn as much as you can, look at all the options, and make your decision
on your child’s treatment based on your child’s needs. You may want to
visit public schools in your area to see the type of program they offer to
special needs children.’’
Clinical Treatment and Research
ClinicalTrials.gov
<http://clinicaltrials.gov>
‘‘ClinicalTrials.gov is a registry of federally and privately supported clinical
trials conducted in the United States and worldwide. ClinicalTrials.gov gives
you information about a trial’s purpose, who may participate, locations, and
phone numbers for more details. This information should be used in con-
junction with advice from health care professionals.’’ This site includes many
clinical studies conducted on autism spectrum disorders.
Interactive Autism Network (IAN)
<http://www.ianproject.org/>
A unique site, IAN states its purpose is to bring patients and researchers
together to advance the pace of research: ‘‘IAN, the Interactive Autism
Network, is an innovative online project designed to accelerate the pace of
autism research by linking researchers and families. Anyone impacted by
an Autism Spectrum Disorder (ASD) can become part of IAN’s online com-
munity to stay informed about autism research, provide feedback, and make
their voices heard.’’
Early and School-based Intervention
The Council for Exceptional Children
<http://www.cec.sped.org/>
In special education, as in other fields, the definition of evidence-based prac-
tices is still being determined. CEC is an international organization that advo-
cates for appropriate policies and standards to support those educating
individuals with disabilities and exceptional talents. While the evidence-
based practice discussion continues, CEC is assisting educators in selecting
practices that are empirically supported: ‘‘CEC is taking a leading role in
defining and presenting evidence-based practices for the field. CEC’s Profes-
sional Standards & Practice Committee has developed a comprehensive
proposal for evidence-based practices. The proposal will select criteria to
identify evidence-based practices and develop a process by which CEC
would identify these practices.’’
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Interagency Autism Coordinating Committee (IACC)
<http://iacc.hhs.gov/reports/>
The IACC was established to comply with the Combating Autism Act of 2006.
Several seminal reports have been issued that are directly affecting both prac-
tice and research of ASD-related issues. From the site: ‘‘The EWG is a diverse
group comprising of members with special ASD expertise—service provi-
ders, educators, community program coordinators, researchers, individuals
with ASD, and family members of individuals with ASD. The EWG was asked
to review the state of the field and identify principles of best practices,
challenges, and recommendations to provide the blueprint for a national
public and private implementation plan for expanding and improving ASD
services.’’
Autism Society of America (ASA): Individualized Education Plan
<http://www.autism-society.org/site/
PageServer?pagename=life_edu_IEP>
Generally, ASA is an advocacy group that also provides information to par-
ents. This page describes the basic purpose and guidelines of an Individu-
alized Education Plan, as mandated by the Individuals with Disabilities
Education Improvement Act (IDEIA). In describing the relevant federal
statutes (IDEA, IDEIA, and NCLB), this article describes in plain language
the basic educational rights of students and their caregivers. The process
of developing the IEP, elements, and relevant inputs are described generally.
The IEP is a federally mandated tool for individualizing education for stu-
dents with special needs; this article provides a clear and simple introduction.
Laws and Legal Rights
Fortunately, there are federal laws that mandate Free and Appropriate Educa-
tion (FAPE) for individuals with certain disabilities. The relevant federal
education laws are the Individuals with Disabilities Education Act (IDEA),
the Individuals with Disabilities Education Improvement Act (IDEIA), and
No Child Left Behind (NCLB). In addition, individuals with disabilities are
covered more generally in the Americans with Disabilities Act (ADA).
ED.gov: Individuals with Disabilities Education Act (IDEA) 2004
<http://idea.ed.gov/>
This is the official site for IDEA by the U.S. Department of Education. ‘‘The
Individuals with Disabilities Education Act is a law ensuring services to chil-
dren with disabilities throughout the nation. IDEA governs how states and
public agencies provide early intervention, special education and related ser-
vices to more than 6.5 million eligible infants, toddlers, children, and youth
with disabilities.’’
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No Child Left Behind (NCLB)
<http://www.ed.gov/nclb/landing.jhtml>
This is the official site of the NCLB. There are many tools available for parents
and professionals, but navigating the site may be challenging.
Americans with Disabilities Act (ADA)
<http://www.ada.gov/cguide.htm>
This is a guide for consumers to the ADA on the official ADA site. Relevant
topics to ASDs include employment, public transportation, and accommoda-
tions. ‘‘The ADA prohibits discrimination on the basis of disability in employ-
ment, state and local government, public accommodations, commercial
facilities, transportation, and telecommunications. It also applies to the Uni-
ted States Congress. To be protected by the ADA, one must have a disability
or have a relationship or association with an individual with a disability. An
individual with a disability is defined by the ADA as a person who has a
physical or mental impairment that substantially limits one or more major life
activities, a person who has a history or record of such as impairment, or a
person who is perceived by others as having such an impairment. The
ADA does not specifically name all of the impairments that are covered.’’
CONCLUSION
Autism is a developmental disorder distinguished from others by significant
impairments in social relating skills. An individual with an ASD can make
progress if appropriate goals are set but will never outgrow their disorder.
Research indicates that early intervention offers significant positive differ-
ences when compared to later interventions.7 As research continues to shed
light on the causes of and effective treatments for ASDs, the information
available will converge; until that time, it is necessary to exercise caution
when searching for information. This guide should enable both librarians
and consumers who are new to the area to find relevant, empirically
supported information that addresses specific needs.
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